# Erector Spinae Block With Ropivacaine and Dexmedetomidine on Opioid Consumption After Lumar Spine Surgeries

> **NCT05664542** · PHASE4 · UNKNOWN · sponsor: **Security Forces Hospital** · enrollment: 42 (estimated)

## Conditions studied

- Postoperative Pain

## Interventions

- **OTHER:** ESPB (regional Block)
- **DRUG:** ropivacaine and dexmedetomidine

## Key facts

- **NCT ID:** NCT05664542
- **Lead sponsor:** Security Forces Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-12-15
- **Primary completion:** 2023-04-30
- **Final completion:** 2023-05-30
- **Target enrollment:** 42 (ESTIMATED)
- **Last updated:** 2023-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05664542

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05664542, "Erector Spinae Block With Ropivacaine and Dexmedetomidine on Opioid Consumption After Lumar Spine Surgeries". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05664542. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*